In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Change of Control: Why Getting it Right Matters Even More

Executive Summary

Private biotechs' growing dependence on an M&A exit and the more lively acquisition activity throughout the sector means change of control provisions are being far more heavily negotiated than in the past, and it's critical to understand how far-reaching these provisions could be for biotechs hoping for successful exits.
Advertisement

Related Content

Repercussions Of A Merger: TRU-015 Potentially Up For Grabs
Infinity Regains Rights To Its Lead Program
Regulatory Risk and Business Development: Type 2 Diabetes Falls Out of Favor
Regulatory Risk and Business Development: Type 2 Diabetes Falls Out of Favor
How Risky Is Too Risky?
How Risky Is Too Risky?
Dynogen Tries the SPAC Alternative
Genzyme/Isis: Has ENHANCE Dulled Mipomersen's Prospects?
Genzyme/Isis: Has ENHANCE Dulled Mipomersen's Prospects?
Infinity Reverse Merges Into Discovery Partners

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003080

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel